Chemotherapy News and Research

Latest Chemotherapy News and Research

Scientists receive critical funding to study treatments for three deadly cancers

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer.

17 Oct 2017

Factors associated with disparities in breast cancer survival studied

According to a latest study, several factors are responsible for the differences in the survival statistics of the non-elderly women with breast cancer. For example in 2012, the health reports had revealed that black women have a 43% higher risk of death when affected with breast cancer compared to their white counterparts.

16 Oct 2017

CHLA and Keck Medicine of USC develop new liquid biopsy for tumor of the retina

Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed using a biopsy, retinoblastoma tumors cannot be directly biopsied.

16 Oct 2017

Powering up fat cells could help acute myeloid leukemia patients

Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

16 Oct 2017

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

Stand Up To Cancer has awarded a $2.5 million SU2C CatalystR grant to the Translational Genomics Research Institute to investigate a revolutionary new method of treating pancreatic cancer, one of the most aggressive of all cancers.

13 Oct 2017

New study describes unique role of androgens in kidney cancer

A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.

13 Oct 2017

USC discovery may one day lead to new therapies for liver cancer

A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate that continues to balloon.

12 Oct 2017

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up 2 Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer.

12 Oct 2017

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.

12 Oct 2017

Researchers find potential approach to prevent peripheral neuropathy

In discovering how certain chemotherapy drugs cause the nerve damage known as peripheral neuropathy, researchers at Dana-Farber Cancer Institute have found a potential approach to preventing this common and troublesome side effect of cancer treatment.

11 Oct 2017

Survey highlights major gap in women’s knowledge about genomic testing in breast cancer

Breast cancer is the most feared type of cancer among women in Germany, according to a recent representative survey commissioned by Agendia, a world leader in personalized medicine and molecular cancer diagnostics.

11 Oct 2017

FDA approved drug found to have anti-cancer activity against previously unknown targets

Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative strategies to identify and test new drugs quicker and more efficiently.

10 Oct 2017

Experts indicate new way via which tumor cells can respond to chemotherapy

An international group of researchers, with the participation of the members of the University of Seville and the Andalusian Centre of Molecular Biology and Regenerative Medicine has just published a study in the prestigious review Science, in which they describe a new methodology for making tumor cells behave when submitted to chemotherapy, which, in the hope of new treatments, continues to be a fundamental tool in the fight against cancer.

10 Oct 2017

New treatment approach makes cancer cells commit suicide while sparing healthy cells

Scientists at Albert Einstein College of Medicine have discovered the first compound that directly makes cancer cells commit suicide while sparing healthy cells.

9 Oct 2017

Blood samples may help identify most sensitive patients before radiation and chemotherapy

How much radiation or chemotherapy can a certain person handle? With help from blood or tissue testing, it may be possible to answer this question in advance, which in turn could improve treatment, as research at Sahlgrenska Academy shows.

9 Oct 2017

Study reveals how different breast cancer treatments impact employment experiences of women

A new study reveals that patients with breast cancer who received more aggressive treatments were more likely to experience disruptions in employment. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may be helpful for patients who are comparing their options for breast cancer treatment.

9 Oct 2017

New topical treatment to combat skin cancer yields promising results in preliminary study

Researchers at the University of São Paulo (USP), in Brazil, are testing a technique in mice that combines low-intensity electric current with a formulation containing nanoencapsulated chemotherapy to treat skin cancer.

6 Oct 2017

Primary care practices unable to meet health care needs of cancer survivors, study finds

Primary care medicine is currently not able to meet the health care needs of cancer survivors, despite a decade-long effort by the medical establishment to move long-term survivorship care out of the specialists' realm, according to a new Rutgers study.

6 Oct 2017

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

6 Oct 2017

Study to determine lowest dose of chemotherapy needed for babies with SCID

Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, MD, of Boston Children's Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID) which prevents the immune system from functioning normally.

6 Oct 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

Scientists receive critical funding to study treatments for three deadly cancers

Factors associated with disparities in breast cancer survival studied

CHLA and Keck Medicine of USC develop new liquid biopsy for tumor of the retina

Powering up fat cells could help acute myeloid leukemia patients

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

New study describes unique role of androgens in kidney cancer

USC discovery may one day lead to new therapies for liver cancer

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Researchers find potential approach to prevent peripheral neuropathy

Survey highlights major gap in women’s knowledge about genomic testing in breast cancer

FDA approved drug found to have anti-cancer activity against previously unknown targets

Experts indicate new way via which tumor cells can respond to chemotherapy

New treatment approach makes cancer cells commit suicide while sparing healthy cells

Blood samples may help identify most sensitive patients before radiation and chemotherapy

Study reveals how different breast cancer treatments impact employment experiences of women

New topical treatment to combat skin cancer yields promising results in preliminary study

Primary care practices unable to meet health care needs of cancer survivors, study finds

Markey's cancer researcher wins NIH's New Innovator Award

Study to determine lowest dose of chemotherapy needed for babies with SCID

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in